Skip to main content

Month: June 2021

Unigold Announces the Appointment of Steve Haggarty to the Board of Directors

TORONTO, June 01, 2021 (GLOBE NEWSWIRE) — Unigold Inc. (“Unigold” or the “Company”) (TSX-V:UGD; OTCQX: UGDIF; FSE:UGB1) is pleased to announce that the Board of Directors has appointed Mr. Steve Haggarty to the Board of the Company. Mr. Steve Haggarty, P.Eng., is the Managing Director of Haggarty Technical Services Corp., a consulting engineering company providing project, process and risk management services to the mining industry. Prior to forming Haggarty Technical Services, Mr. Haggarty had a lengthy 40 year career with companies including Barrick Gold, Homestake Mining, International Corona and Teck Corporation. His metallurgical background and operational experience includes copper, molybdenum, gold, silver and PGM group metals at mining operations involving copper SX-EW, flotation, heap leaching, pressure oxidation, roasting...

Continue reading

CORRECTING and REPLACING — Dada to Announce First Quarter 2021 Unaudited Financial Results on June 7, 2021

SHANGHAI, June 01, 2021 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Dada Group (Nasdaq:DADA) please note that in the first paragraph of the release, the quarter ended date should be March 31, 2021, not March 31, 2020 as previously stated. The corrected release follows: Dada Group (DADA, “Dada” or the “Company”), a leading platform for local on-demand retail and delivery in China, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2021, on Monday, June 7, 2021, after the close of U.S. markets. The Company will host a conference call to discuss the earnings at 9:00 p.m. Eastern Time on Monday, June 7, 2021 (9:00 a.m. Beijing time on Tuesday, June 8, 2021). Please register in advance of the conference using the link provided below and dial...

Continue reading

Drug Discovery Informatics Market 2021-2028 | Size, Share, Growth, Trends, Revenue, Competitive Landscape, Forecast Report

Top Players Covered in the Drug Discovery Informatics Market Research Report Are PerkinElmer Inc., Charles River, Infosys Limited, International Business Machines Corporation (IBM), Accenture, Amazon Web Services, Schrödinger LLC., Boehringer Ingelheim International GmbH, Accenture, CORE INFORMATICS, Informatics Matters Ltd., Tata Consultancy Services Limited and other key market players. Pune, India, June 01, 2021 (GLOBE NEWSWIRE) — Global Drug Discovery Informatics Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2026 is latest study published by Fortune Business Insights. Real-time insights with the help of drug discovery informatics is a key factor driving the global drug discovery...

Continue reading

Gold Bull encounters coarse gold in samples at Sandman, improved laboratory assay analysis underway – higher grades expected

Figure 1Cross-plot on logarithmic axes of metallic screen fire assay versus fire assay determinations on selected samples from SA-0001 and SA-0004VANCOUVER, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) — Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) is pleased to report re-assay results of RC drill samples from the high-grade gold intersections at North Hill and Abel Knoll using the metallic screen fire assay method (with ICP or gravimetric finish as appropriate). This variation, caused by the presence of coarse gold, highlights the need for a change in the Company’s assay protocols to ensure that samples likely to contain coarse gold will return repeatable assay results suitable for inclusion in a mineral resource estimate and, that all mineralization with gold above the cut-off grade...

Continue reading

SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

STAMFORD, Conn., June 01, 2021 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that management will participate in a Fireside Chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8th at 3:00PM ET. To access the live webcast please visit the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for a limited time following the conference. About SpringWorks TherapeuticsSpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing...

Continue reading

Rugby Completes Detailed Sampling / Magnetics at El Zanjon Gold-Silver Project, Argentina

VANCOUVER, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) — Rugby Mining Limited (“Rugby” or the “Company”) (TSX-V: RUG) is pleased to report that previously reported gold-silver anomalies have been followed up with a third round of exploration on the El Zanjon property. The project is south of the high-grade Cerro Vanguardia mine in Argentina (Figure 1). A total of 506 soil samples and 422-line kilometres of ground magnetics were completed. Results are awaited.   Yale Simpson, Rugby’s Chairman stated: “We continue to be encouraged by the way targets are emerging from what began as a conceptual gold play. The soil sampling is now on 160 metre spaced lines with the ground magnetics on 80 metre lines. The results will determine whether another program of soil sampling is necessary before drill targeting. Fortunately, our team has...

Continue reading

CENTOGENE Launches NEW CentoXome® – An Enhanced Whole Exome Sequencing Solution

World leader and trusted partner in rare diseases releases enhanced Whole Exome Sequencing (WES) solution to improve diagnosis in complex and unsolved patient cases NEW CentoXome® provides best-in-class clinical insights based on CENTOGENE’s unique rare disease-centric Bio/Databank, enabling more rapid diagnosis and identification of treatment options Superior technology with excellent clinical coverage and diagnostic power in a single test increases diagnostic yield by up to 20% compared to routine WES Life-long support with free-of-charge and proactive variant reclassification demonstrates unique commitment to improving the lives of patients with rare diseasesCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 01, 2021 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven...

Continue reading

Headwater Gold Inc. Files Final Prospectus

Headwater Gold Inc. (the “Company” or “Headwater”) is pleased to announce that the Company has obtained the final receipt for its non-offering prospectus from the British Columbia Securities Commission on May 31, 2021. Vancouver, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) — Headwater Gold Inc. (the “Company” or “Headwater”) is pleased to announce that the Company has obtained the final receipt for its non-offering prospectus from the British Columbia Securities Commission on May 31, 2021. Headwater previously received conditional approval to list the Company’s common shares (the “Common Shares”) on the Canadian Securities Exchange (the “CSE”).  Having filed the Final Prospectus, the Company expects to complete its listing and to have the Common Shares commence trading on the...

Continue reading

Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Update

New Chief Technology Officer (CTO) appointed to accelerate innovation and further strengthen organizational capabilities Continuing robust progress in advancing the MosaiQ transfusion diagnostics menu Actively preparing for commercialization of MosaiQ products through planned evaluation placements in Europe Exploring potential partnerships across a broad range of applications for the multimodal and multiplexing MosaiQ by Quotient system Continued strong Alba by Quotient revenues with high single digit growth in Q4 FY21, exceeded full-year guidance Further strengthened cash position through private placement of Convertible Senior NotesJERSEY, Channel Islands, June 01, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland,...

Continue reading

Turnover of Apranga Group in May 2021

Retail turnover (including VAT) of Apranga Group amounted to EUR 18.6 million in May 2021 and has increased by 23.8% comparing to May 2020. In May 2021, the retail turnover of Apranga Group in Lithuania increased by 39.9% year-to-year, in Latvia decreased by 28.5% and in Estonia increased by 47.8%. Due to epidemic coronavirus (COVID-19) infection, from 16 December 2020, all the Group’s stores in Lithuania were temporarily closed. Stores in Lithuania with a separate entrance from outside and a sales area not exceeding 300 square meters had been open since 15 February 2021. All stores with a separate entrance from outside had been open since 15 March 2021. All Group’s stores have been reopened in Lithuania from 19 April 2021, however, stores operating in shopping malls were not allowed to work on weekends, unless they had separate entrance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.